(Q34353041)

English

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies (English)

1 reference

Europe PubMed Central

1 August 2017

1 reference

based on heuristic

inferred from title

Neisseria meningitidis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gunnstein Norheim

11

object named as

Gunnstein Norheim

1 reference

Europe PubMed Central

1 August 2017

10

object named as

Andrew J Pollard

1 reference

Europe PubMed Central

1 August 2017

author name string

Ouli Xie

1

1 reference

Europe PubMed Central

1 August 2017

Barbara Bolgiano

2

1 reference

Europe PubMed Central

1 August 2017

Fang Gao

3

1 reference

Europe PubMed Central

1 August 2017

Kay Lockyer

4

1 reference

Europe PubMed Central

1 August 2017

Carolyn Swann

5

1 reference

Europe PubMed Central

1 August 2017

Christopher Jones

6

1 reference

Europe PubMed Central

1 August 2017

Isabelle Delrieu

7

1 reference

Europe PubMed Central

1 August 2017

Berthe-Marie Njanpop-Lafourcade

8

1 reference

Europe PubMed Central

1 August 2017

Tsidi Agbeko Tamekloe

9

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

24 July 2012

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

30

1 reference

Europe PubMed Central

1 August 2017

40

1 reference

Europe PubMed Central

1 August 2017

5812-5823

1 reference

Europe PubMed Central

1 August 2017

Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Serogroup X in meningococcal disease, Western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Multi-locus sequence typing: a tool for global epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Serologic correlates of protection for evaluating the response to meningococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Full NMR assignment and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 15B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Evaluation of meningococcal C oligosaccharide conjugate vaccines by size-exclusion chromatography/multi-angle laser light scattering

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Chemical structure, conjugation, and cross-reactivity of Bacillus pumilus Sh18 cell wall polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Spectrophotometry as a Tool for Assaying Endotoxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Simultaneous determination of glucosamine and glucosamine 4-phosphate in Lipid A with high-performance anion-exchange chromatography (HPAEC)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Quantitative Determination of the Human Immune Response to Immunization with Meningococcal Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

The polysialic acid-specific O-acetyltransferase OatC from Neisseria meningitidis serogroup C evolved apart from other bacterial sialate O-acetyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Prevalence of de-O-acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

O-Acetylation status of the capsular polysaccharides of serogroup Y and W135 meningococci isolated in the UK

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzae type b polysaccharides in association with isolated outer membranes and in immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Covalently linked peptides for enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Two enzyme linked immunosorbent assays for detecting antibodies against meningococcal capsular polysaccharides A and C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Quadrivalent meningococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.07.032

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34353041&oldid=1975626159"